Literature DB >> 7009265

Prevention of diabetic nephropathy by diet control in the db/db mouse.

S M Lee, R Bressler.   

Abstract

Diabetes in the C57BL/KsJ(db/db) mouse is initially expressed as hyperinsulinemia, followed by hyperphagia, progressive obesity, and widespread pathologic abnormalities. This study was designed to evaluate the effects of metabolic control on the natural history of the diabetic nephropathy. Beginning at 1 mo of age and continuing for 12 wk, diabetic mice were subjected to controlled dietary restriction, such that their weight was maintained similar to that of age-matched, nondiabetic heterozygotes. Diet-restricted diabetics were compared with diabetics fed ad libitum and heterozygote nondiabetics. Significant lowering of fasting blood glucose, water intake, and plasma insulin was achieved by diet restriction. The diet-restricted diabetes demonstrated enhanced metabolic efficiency, consuming approximately half as much food as the nondiabetics, while maintaining a similar weight. Diabetics fed ad libitum evidenced well-defined renal lesions that included 3 + to 4 + immunoglobulin deposition in the glomerular mesangium, and generalized mesangial matrix expansion. These lesions were completely prevented in diet-restricted diabetes whose glomeruli were normal light microscopy, and demonstrated trace to 1 + mesangial immunoglobulin deposition, features identical in all respects to the nondiabetics. These results indicate that diabetic control achieved by preventing of obesity in the db/db mouse prevents the development of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7009265     DOI: 10.2337/diab.30.2.106

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

1.  Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes.

Authors:  M Friederich Persson; S Franzén; S-B Catrina; G Dallner; P Hansell; K Brismar; F Palm
Journal:  Diabetologia       Date:  2012-02-05       Impact factor: 10.122

2.  Glucocorticoid-Induced Metabolic Disturbances Are Exacerbated in Obese Male Mice.

Authors:  Innocence Harvey; Erin J Stephenson; JeAnna R Redd; Quynh T Tran; Irit Hochberg; Nathan Qi; Dave Bridges
Journal:  Endocrinology       Date:  2018-06-01       Impact factor: 4.736

3.  Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.

Authors:  K Arakawa; T Ishihara; A Oku; M Nawano; K Ueta; K Kitamura; M Matsumoto; A Saito
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 4.  Impact of diet restriction in the management of diabetes: evidences from preclinical studies.

Authors:  Pawan Krishan; Onkar Bedi; Monika Rani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-16       Impact factor: 3.000

5.  In Vivo Tracking of Streptococcal Infections of Subcutaneous Origin in a Murine Model.

Authors:  Richard W Davis; Heather Eggleston; Frances Johnson; Matthias Nahrendorf; Paul E Bock; Tiffany Peterson; Peter Panizzi
Journal:  Mol Imaging Biol       Date:  2015-12       Impact factor: 3.488

6.  Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract.

Authors:  Yoriko Deguchi; Kouji Miyazaki
Journal:  Nutr Metab (Lond)       Date:  2010-02-02       Impact factor: 4.169

7.  Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia.

Authors:  B Vasquez; E V Flock; P J Savage; M Nagulesparan; L J Bennion; H R Baird; P H Bennett
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

8.  The effect of a high fibre diet on diabetic nephropathy in the db/db mouse.

Authors:  S M Lee
Journal:  Diabetologia       Date:  1982-05       Impact factor: 10.122

Review 9.  Use of genetic mouse models in the study of diabetic nephropathy.

Authors:  Terri J Allen; Mark E Cooper; Hui Y Lan
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

10.  Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.

Authors:  M P Cohen; K Sharma; Y Jin; E Hud; V Y Wu; J Tomaszewski; F N Ziyadeh
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.